Mifepristone was recently approved in the United States. Regimens with shorter intervals
may be more acceptable. The objective of this study was to determine whether the oral route …

Objectives To evaluate the efficacy and safety of mifepristone and buccal misoprostol versus
buccal misoprostol alone in medical abortion of≤ 56 days. Study design One hundred …

Objectives To compare the side effect profiles of regimens of oral and vaginal administration
of misoprostol after a single oral dose of 200 mg of mifepristone and to investigate patients' …

OBJECTIVE: To estimate the proportion of obstetrician–gynecologists (ob-gyns) who
provided induced abortion in the prior year, disaggregated by surgical and medication …

OBJECTIVES: Extensive data from clinical trials document mifepristone's safety and efficacy
for induced abortion, but less information is available about its safety in routine clinical use …

Objectives To compare the efficacy of oral and vaginal administration of misoprostol after a
single oral dose of 200 mg of mifepristone and to investigate whether the efficacy can be …

DESIGN: A retrospective analysis of 386 women who underwent termination of pregnancy
between 12 and 24 weeks' gestation. METHODS: Each woman received 200 mg …

OBJECTIVE: To evaluate the safety and efficacy of oral methotrexate and vaginal
misoprostol for medical abortion. METHODS: A prospective multicenter trial involved 300 …

Objectives This open-label non-inferiority study assessed efficacy of a common outpatient
medical abortion regimen among people with pregnancies 64–70 days and 71–77 days of …

BACKGROUND: The dose of mifepristone approved by most government agencies for
medical abortion is 600 mg. Our aim was to summarize extant data on the effectiveness and …